Public company info - YiChang HEC ChangJiang Pharmaceutical Co. Ltd. - H Shares , 01558.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. - H Shares, 01558.HK - Cash Flow 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12
Net Cash Flow from Operating Activities 1,552,024 2,135,561 926,494 760,116 448,999 343,998 146,910 60,838 98,209
Net Cash Flow from Return on Investments & Servicing of Finance -290,219 -721,842 -303,249 -306,073 -66,973 -23,024 -42,359 -48,966 -41,866
　Interest Received 24,987 36,038 14,601 14,737 8,104 2,172 242 513 346
　Interest Paid -95,216 -37,846 -1,434 -4,394 -7,454 -25,196 -42,601 -49,479 -42,212
　Dividend Received 0 0 0 0 0 0 0 0 0
　Dividend Paid -219,990 -720,034 -316,416 -316,416 -67,623 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -252,531 -341,154 -211,102 -89,365 -51,793 -56,604 -17,032 -9,292 -19,687
Net Cash Flow from Investing Activities -2,119,615 -1,746,521 -743,131 -627,108 -375,813 -345,747 -38,583 -73,131 -140,195
　Additions to Fixed Assets -994,159 -576,276 -620,039 -327,036 -62,987 -28,004 -35,470 -76,438 -140,238
　Disposal of Fixed Assets 19,619 4,537 0 367 0 5,257 73 3,307 43
　Increase in Investments 0 -78,159 0 -137,402 0 -33,000 0 0 0
　Decrease in Investments 0 0 0 0 0 0 -3,186 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 -30,091 173,881 -61,528 -122,667
　Others -1,145,075 -1,096,623 -123,092 -163,037 -312,826 -259,909 -173,881 61,528 122,667
Net Cash Flow before Financing Activities -1,110,341 -673,956 -330,988 -262,430 -45,580 -81,377 48,936 -70,551 -103,539
Net Cash Flow from Financing Activities 379,839 2,857,899 33,399 -50,656 -125,551 1,348,474 5,251 71,682 58,966
　New Loans 518,006 713,201 43,399 0 0 50,000 294,310 461,270 555,953
　Loans Repayment -1,250 -290,000 -10,000 -70,000 -105,000 -270,000 -462,940 -328,060 -374,320
　Fixed Income/Debt Instruments 0 2,680,657 0 0 0 1,613,481 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 19,344 1,984 -14,916 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 -30,091 173,881 -61,528 -122,667
　Others -136,917 -245,959 0 0 -22,535 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents -730,502 2,183,943 -297,589 -313,086 -171,131 1,267,097 54,187 1,131 -44,573
Cash & Cash Equivalents at Beginning of Year 2,779,138 593,746 887,183 1,212,072 1,353,651 86,554 32,367 31,236 75,809
Net Cash Flow due to Change in Exchange Rate/Others -3,669 1,449 4,152 -11,803 29,552 0 0 0 0
Cash & Cash Equivalents at End of Year 2,044,967 2,779,138 593,746 887,183 1,212,072 1,353,651 86,554 32,367 31,236
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved